MA23663A1 - PROCESS FOR THE PREPARATION OF PHARMACEUTICAL FORMULATIONS - Google Patents

PROCESS FOR THE PREPARATION OF PHARMACEUTICAL FORMULATIONS

Info

Publication number
MA23663A1
MA23663A1 MA24005A MA24005A MA23663A1 MA 23663 A1 MA23663 A1 MA 23663A1 MA 24005 A MA24005 A MA 24005A MA 24005 A MA24005 A MA 24005A MA 23663 A1 MA23663 A1 MA 23663A1
Authority
MA
Morocco
Prior art keywords
preparation
pharmaceutical formulations
formulations
pharmaceutical
Prior art date
Application number
MA24005A
Other languages
French (fr)
Inventor
John Crowley Patrick
Original Assignee
Smithkline Beecham Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB9417953A external-priority patent/GB9417953D0/en
Priority claimed from GBGB9503752.9A external-priority patent/GB9503752D0/en
Application filed by Smithkline Beecham Plc filed Critical Smithkline Beecham Plc
Publication of MA23663A1 publication Critical patent/MA23663A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/42—Oxazoles
    • A61K31/424—Oxazoles condensed with heterocyclic ring systems, e.g. clavulanic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/429—Thiazoles condensed with heterocyclic ring systems
    • A61K31/43—Compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula, e.g. penicillins, penems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
MA24005A 1994-09-03 1995-09-01 PROCESS FOR THE PREPARATION OF PHARMACEUTICAL FORMULATIONS MA23663A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB9417953A GB9417953D0 (en) 1994-09-03 1994-09-03 Pharmaceutical formulations
GBGB9503752.9A GB9503752D0 (en) 1995-02-24 1995-02-24 Pharmaceutical formulations
US46044195A 1995-06-02 1995-06-02

Publications (1)

Publication Number Publication Date
MA23663A1 true MA23663A1 (en) 1996-04-01

Family

ID=27267365

Family Applications (1)

Application Number Title Priority Date Filing Date
MA24005A MA23663A1 (en) 1994-09-03 1995-09-01 PROCESS FOR THE PREPARATION OF PHARMACEUTICAL FORMULATIONS

Country Status (8)

Country Link
EP (1) EP0782443A1 (en)
JP (1) JPH10505595A (en)
AU (1) AU3471995A (en)
DZ (1) DZ1926A1 (en)
IL (1) IL115125A0 (en)
MA (1) MA23663A1 (en)
TR (1) TR199501082A2 (en)
WO (1) WO1996007408A1 (en)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CZ299595B6 (en) 1995-09-07 2008-09-17 Smithkline Beecham Plc Pharmaceutical formulation and medicament for empiric treatment of infections
JP2001512451A (en) * 1997-02-14 2001-08-21 スミスクライン・ビーチャム・ラボラトワール・ファルマソーティク Pharmaceutical formulations containing amoxicillin and clavulanate
US6706290B1 (en) 1998-07-06 2004-03-16 Olvai E. Kajander Methods for eradication of nanobacteria
DE69922202T2 (en) * 1998-07-06 2005-12-01 Nanobac Oy METHOD OF REMOVING NANOBAKTERIA
US6878386B1 (en) 1999-04-13 2005-04-12 Beecham Pharmaceuticals (Pte) Limited Method of treating a bacterial infection comprising amoxycillin and potassium clavulanate
US7250176B1 (en) 1999-04-13 2007-07-31 Beecham Pharmaceuticals (Pte) Limited Method of treating a bacterial infection
US6294199B1 (en) 1999-04-13 2001-09-25 Beecham Pharmaceuticals (Pte) Limited Method of treating a bacterial infection comprising administering amoxycillin
US6756057B2 (en) 2000-10-12 2004-06-29 Beecham Pharmaceuticals (Pte) Limited Amoxicillin and potassium clavulanate dosage form
WO2002030392A2 (en) 2000-10-12 2002-04-18 Beecham Pharmaceuticals (Pte) Limited Formulation containing amoxicillin
US8614315B2 (en) * 2009-12-25 2013-12-24 Mahmut Bilgic Cefdinir and cefixime formulations and uses thereof
TR201000688A2 (en) 2010-01-29 2011-08-22 B�Lg�� Mahmut Effervescent formulations containing cefaclor and clavulanic acid as active ingredient.
EP2575781A1 (en) * 2010-06-03 2013-04-10 Mahmut Bilgic Production method for the effervescent formulation comprising cephalosporin and potassium clavulanate

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0002312B1 (en) * 1977-11-26 1982-02-03 Beecham Group Plc Derivatives of clavulanic acid and pharmaceutical compositions containing them
NZ198241A (en) * 1980-09-27 1983-12-16 Beecham Group Ltd Tablet containing amoxycillin and potassium clavulanate
EP1034784A3 (en) * 1993-01-22 2001-06-27 Smithkline Beecham Plc Pharmaceutical formulations containing clavulanic acid and an antibacterial agent

Also Published As

Publication number Publication date
DZ1926A1 (en) 2002-02-17
IL115125A0 (en) 1995-12-31
JPH10505595A (en) 1998-06-02
EP0782443A1 (en) 1997-07-09
AU3471995A (en) 1996-03-27
WO1996007408A1 (en) 1996-03-14
TR199501082A2 (en) 1996-06-21

Similar Documents

Publication Publication Date Title
MA23528A1 (en) PROCESS FOR THE PREPARATION OF PHARMACEUTICAL PRODUCTS
FR2722984B1 (en) PROCESS FOR THE PREPARATION OF DRY PHARMACEUTICAL FORMS AND THE PHARMACEUTICAL COMPOSITIONS THUS PRODUCED
MA23850A1 (en) PROCESS FOR THE PREPARATION OF VACCINATION COMPOSITIONS
MA23918A1 (en) PROCESS FOR THE PREPARATION OF VACCINATION COMPOSITIONS
MA23814A1 (en) PROCESS FOR THE PREPARATION OF VACCINATION COMPOSITIONS
MA23395A1 (en) PROCESS FOR THE PREPARATION OF NEW FORMULATIONS
ITMI950529A0 (en) PHARMACEUTICAL COMPOSITIONS AND PROCEDURE FOR THEIR PREPARATION
MA22842A1 (en) PROCESS FOR THE PREPARATION OF VACCINE COMPOSITIONS.
MA26410A1 (en) PHARMACEUTICAL FORMULATIONS AND PROCESS FOR THEIR PRODUCTION.
MA24291A1 (en) PROCESS FOR THE PREPARATION OF VACCINE COMPOSITIONS
MA24437A1 (en) PROCESS FOR THE PREPARATION AND FORMULATION OF EPROSARTAN DIHYDRATE
FR2722210B1 (en) NOVEL STREPTOGRAMINS AND PROCESS FOR THE PREPARATION OF STREPTOGRAMINS BY MUTASYNTHESIS
MA23518A1 (en) PROCESS FOR THE PREPARATION OF PHARMACEUTICAL PRODUCTS
MA24246A1 (en) PROCESS FOR THE PREPARATION OF IMPROVED OVEN-FRIED FRIES
MA23663A1 (en) PROCESS FOR THE PREPARATION OF PHARMACEUTICAL FORMULATIONS
FR2728895B1 (en) PROCESS FOR THE PREPARATION OF DIFLUOROMETHANE
MA24183A1 (en) PROCESS FOR THE PREPARATION OF PHARMACEUTICAL COMPOSITIONS BASED ON DICLOFENAC
FR2768725B1 (en) PROCESS FOR THE PREPARATION OF 2-CHLOROPROP-1-ENE
FR2728268B1 (en) PROCESS FOR THE PREPARATION OF GAMMA-CYCLODEXTRIN
ITMI951417A0 (en) PHARMACEUTICAL COMPOSITIONS AND PROCEDURE FOR THEIR PREPARATION
MA22880A1 (en) PROCESS FOR THE PREPARATION OF PHARMACEUTICAL PRODUCTS.
MA23096A1 (en) PROCESS FOR THE PREPARATION OF DRUG PRECURSORS OF 3-ACYL-2-OXINDOLE-1-CARBOXAMIDES ANTI-INFLAMMATORY
NO20003393D0 (en) Process for the preparation of a pharmaceutical formulation
NO980384L (en) Process for the preparation of solid dosage forms of very low-dose drugs
IT1277117B1 (en) PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF HYPERCHOLESTEROLEMIA